Robert E. Hoffman

2013

In 2013, Robert E. Hoffman earned a total compensation of $1.5M as Former Senior Vice President, Finance and Chief Financial Officer at Arena Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,500
Option Awards$235,374
Salary$360,000
Stock Awards$710,400
Other$16,041
Total$1,470,315

Hoffman received $710.4K in stock awards, accounting for 48% of the total pay in 2013.

Hoffman also received $148.5K in non-equity incentive plan, $235.4K in option awards, $360K in salary and $16K in other compensation.

Rankings

In 2013, Robert E. Hoffman's compensation ranked 5,019th out of 12,286 executives tracked by ExecPay. In other words, Hoffman earned more than 59.1% of executives.

ClassificationRankingPercentile
All
5,019
out of 12,286
59th
Division
Manufacturing
1,729
out of 4,612
63rd
Major group
Chemicals And Allied Products
496
out of 1,466
66th
Industry group
Drugs
351
out of 1,160
70th
Industry
Pharmaceutical Preparations
280
out of 890
69th
Source: SEC filing on April 28, 2016.

Hoffman's colleagues

We found five more compensation records of executives who worked with Robert E. Hoffman at Arena Pharmaceuticals in 2013.

2013

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2013

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2013

Steven Spector

Arena Pharmaceuticals

General Counsel

2013

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2013

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like